|
1
|
Kharroubi AT and Darwish HM: Diabetes
mellitus: The epidemic of the century. World J Diabetes. 6:850–867.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Al-Rubeaan K, Youssef AM, Subhani SN,
Ahmad NA, Al-Sharqawi AH, Al-Mutlaq HM, David SK and AlNaqeb D:
Diabetic nephropathy and its risk factors in a society with a type
2 diabetes epidemic: A Saudi National Diabetes Registry-based
study. PLoS One. 9:e889562014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gluhovschi GH, Gluhovschi C, Vlad A, Timar
R, Bob F, Velciov S, Bozdog GH and Petrica L: Diabetic nephropathy
and multiorgan protection. Part I. Rom J Intern Med. 49:163–177.
2011.PubMed/NCBI
|
|
4
|
Gluhovschi G, Gluhovschi C, Vlad A, Timar
R, Bob F, Velciov S, Bozdog G and Petrica L: Diabetic nephropathy
and multiorgan protection. Part II. Rom J Intern Med. 49:237–249.
2011.PubMed/NCBI
|
|
5
|
Mooyaart AL, Valk EJ, van Es LA, Bruijn
JA, de Heer E, Freedman BI, Dekkers OM and Baelde HJ: Genetic
associations in diabetic nephropathy: A meta-analysis.
Diabetologia. 54:544–553. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mima A: Inflammation and oxidative stress
in diabetic nephropathy: New insights on its inhibition as new
therapeutic targets. J Diabetes Res. 2013:2485632013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang X and Lu FE: Significance of
anti-inflammation and immune regulation in the treatment of
diabetic nephropathy. Zhongguo Zhong Xi Yi Jie He Za Zhi.
30:649–654. 2010.(In Chinese). PubMed/NCBI
|
|
8
|
Chang YT, Chen CL, Lin CF, Lu SL, Cheng
MH, Kuo CF and Lin YS: Regulatory role of GSK-3β on NF-κB, nitric
oxide, and TNF-α in group A streptococcal infection. Mediators
Inflamm. 2013:7206892013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tanaka S: Signaling axis in osteoclast
biology and therapeutic targeting in the RANKL/RANK/OPG system. Am
J Nephrol. 27:466–478. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Koya D, Haneda M, Nakagawa H, Isshiki K,
Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK, et al:
Amelioration of accelerated diabetic mesangial expansion by
treatment with a PKC beta inhibitor in diabetic db/db mice, a
rodent model for type 2 diabetes. FASEB J. 14:439–447.
2000.PubMed/NCBI
|
|
11
|
Mima A, Ohshiro Y, Kitada M, Matsumoto M,
Geraldes P, Li C, Li Q, White GS, Cahill C, Rask-Madsen C and King
GL: Glomerular-specific protein kinase C-β-induced insulin receptor
substrate-1 dysfunction and insulin resistance in rat models of
diabetes and obesity. Kidney Int. 79:883–896. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ma X, Liu Y, Zhang Y, Yu X, Wang W and
Zhao D: Jolkinolide B inhibits RANKL-induced osteoclastogenesis by
suppressing the activation NF-κB and MAPK signaling pathways.
Biochem Biophys Res Commun. 445:282–288. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Franchimont N, Reenaers C, Lambert C,
Belaiche J, Bours V, Malaise M, Delvenne P and Louis E: Increased
expression of receptor activator of NF-kappaB ligand (RANKL), its
receptor RANK and its decoy receptor osteoprotegerin in the colon
of Crohn's disease patients. Clin Exp Immunol. 138:491–498. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu S, Shi W, Xiao H, Liang X, Deng C, Ye
Z, Mei P, Wang S, Liu X, Shan Z, et al: Receptor activator of
NF-kappaB and podocytes: Towards a function of a novel
receptor-ligand pair in the survival response of podocyte injury.
PLoS One. 7:e413312012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kelly DJ, Hepper C, Wu LL, Cox AJ and
Gilbert RE: Vascular endothelial growth factor expression and
glomerular endothelial cell loss in the remnant kidney model.
Nephrol Dial Transplant. 18:1286–1292. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Berthier CC, Zhang H, Schin M, Henger A,
Nelson RG, Yee B, Boucherot A, Neusser MA, Cohen CD, Carter-Su C,
et al: Enhanced expression of Janus kinase-signal transducer and
activator of transcription pathway members in human diabetic
nephropathy. Diabetes. 58:469–477. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nam JS, Cheong YS, Karm MH, Ahn HS, Sim
JH, Kim JS, Choi SS and Leem JG: Effects of nefopam on
streptozotocin-induced diabetic neuropathic pain in rats. Korean J
Pain. 27:326–333. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Flyvbjerg A, Denner L, Schrijvers BF,
Tilton RG, Mogensen TH, Paludan SR and Rasch R: Long-term renal
effects of a neutralizing RAGE antibody in obese type 2 diabetic
mice. Diabetes. 53:166–172. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
McDonald SD, Pesarchuk E, Don-Wauchope A,
El Zimaity H and Holloway AC: Adverse metabolic effects of a
hypercaloric, high-fat diet in rodents precede observable changes
in body weight. Nutr Res. 31:707–714. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chirinos JA, Segers P, Gillebert TC, De
Buyzere ML, Van Daele CM, Khan ZA, Khawar U, De Bacquer D and
Rietzschel ER: Asklepios Investigators: Central pulse pressure and
its hemodynamic determinants in middle-aged adults with impaired
fasting glucose and diabetes: The Asklepios study. Diabetes Care.
36:2359–2365. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Matia-García I, de la Cruz-Mosso U,
Muñoz-Valle JF and Parra-Rojas I: Macrophage migration inhibitory
factor and its relationship with obesity and diabetes. Invest Clin.
55:266–277. 2014.(In Spanish). PubMed/NCBI
|
|
23
|
Gong R, Rifai A, Ge Y, Chen S and Dworkin
LD: Hepatocyte growth factor suppresses proinflammatory NFκB
activation through GSK3β inactivation in renal tubular epithelial
cells. J Biol Chem. 283:7401–7410. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bouskila M, Hirshman MF, Jensen J,
Goodyear LJ and Sakamoto K: Insulin promotes glycogen synthesis in
the absence of GSK3 phosphorylation in skeletal muscle. Am J
Physiol Endocrinol Metab. 294:E28–E35. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ho C, Lee PH, Hsu YC, Wang FS, Huang YT
and Lin CL: Sustained Wnt/β-catenin signaling rescues high glucose
induction of transforming growth factor-β1-mediated renal fibrosis.
Am J Med Sci. 344:374–382. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ougolkov AV and Billadeau DD: Inhibition
of glycogen synthase kinase-3. Methods Mol Biol. 468:67–75. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kavanagh D, McKay GJ, Patterson CC,
McKnight AJ, Maxwell AP and Savage DA: Warren 3/UK GoKinD Study
Group: Association analysis of Notch pathway signalling genes in
diabetic nephropathy. Diabetologia. 54:334–338. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Holmes T, O'Brien TA, Knight R, Lindeman
R, Symonds G and Dolnikov A: The role of glycogen synthase
kinase-3beta in normal haematopoiesis, angiogenesis and leukaemia.
Curr Med Chem. 15:1493–1499. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Aljada A, Ghanim H, Saadeh R and Dandona
P: Insulin inhibits NFkappaB and MCP-1 expression in human aortic
endothelial cells. J Clin Endocrinol Metab. 86:450–453. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen H, Yang S, Yang Z, Ma L, Jiang D, Mao
J, Jiao B and Cai Z: Inhibition of GSK-3beta decreases
NF-kappaB-dependent gene expression and impairs the rat liver
regeneration. J Cell Biochem. 102:1281–1289. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Baldwin AS Jr: The NF-kappa B and I kappa
B proteins: New discoveries and insights. Annu Rev Immunol.
14:649–681. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Perkins ND: Integrating cell-signalling
pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol.
8:49–62. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Otero JE, Chen T, Zhang K and Abu-Amer Y:
Constitutively active canonical NF-κB pathway induces severe bone
loss in mice. PLoS One. 7:e386942012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Darnay BG, Ni J, Moore PA and Aggarwal BB:
Activation of NF-kappaB by RANK requires tumor necrosis factor
receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase.
Identification of a novel TRAF6 interaction motif. J Biol Chem.
274:7724–7731. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ruocco MG, Maeda S, Park JM, Lawrence T,
Hsu LC, Cao Y, Schett G, Wagner EF and Karin M: I{kappa}B kinase
(IKK){beta}, but not IKK{alpha}, is a critical mediator of
osteoclast survival and is required for inflammation-induced bone
loss. J Exp Med. 201:1677–1687. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Satomi N, Sakurai A and Haranaka K:
Relationship of hypoglycemia to tumor necrosis factor production
and antitumor activity: Role of glucose, insulin, and macrophages.
J Natl Cancer Inst. 74:1255–1260. 1985.PubMed/NCBI
|
|
37
|
Gilbert RE, Kim SA, Tuttle KR, Bakris GL,
Toto RD, McGill JB, Haney DJ, Kelly DJ and Anderson PW: Effect of
ruboxistaurin on urinary transforming growth factor-beta in
patients with diabetic nephropathy and type 2 diabetes. Diabetes
Care. 30:995–996. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ohshiro Y, Ma RC, Yasuda Y,
Hiraoka-Yamamoto J, Clermont AC, Isshiki K, Yagi K, Arikawa E, Kern
TS and King GL: Reduction of diabetes-induced oxidative stress,
fibrotic cytokine expression, and renal dysfunction in protein
kinase Cbeta-null mice. Diabetes. 55:3112–3120. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gao C, Hölscher C, Liu Y and Li L: GSK3: A
key target for the development of novel treatments for type 2
diabetes mellitus and Alzheimer disease. Rev Neurosci. 23:1–11.
2012. View Article : Google Scholar
|
|
40
|
Hinz M and Scheidereit C: The IκB kinase
complex in NF-κB regulation and beyond. EMBO Rep. 15:46–61. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen Y, Gan H, Ouyang Q, Xu D and Pan YAZ:
The effects of anti-inflammatory on activation of nuclear
factor-kappaB and expression of cell adhesion molecules in patients
with ulcerative colitis. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi.
21:732–736. 2004.(In Chinese). PubMed/NCBI
|
|
42
|
Ali A, Hoeflich K and Woodgett JR:
Glycogen synthase kinase-3: Properties, functions, and regulation.
Chem Rev. 101:2527–2540. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
You W, Min X, Zhang X, Qian B, Pang S,
Ding Z, Li C, Gao X, Di R, Cheng Y and Liu L: Cardiac-specific
expression of heat shock protein 27 attenuated endotoxin-induced
cardiac dysfunction and mortality in mice through a
PI3K/Akt-dependent mechanism. Shock. 32:108–117. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
García-García PM, Getino-Melián MA,
Domínguez-Pimentel V and Navarro-González JF: Inflammation in
diabetic kidney disease. World J Diabetes. 5:431–443. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Agrawal NK and Kant S: Targeting
inflammation in diabetes: Newer therapeutic options. World J
Diabetes. 5:697–710. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Duran-Salgado MB and Rubio-Guerra AF:
Diabetic nephropathy and inflammation. World J Diabetes. 5:393–398.
2014. View Article : Google Scholar : PubMed/NCBI
|
